Cilo Cybin is a medical cannabis investment company today transitions from its 2024 AltX listing to the JSE Main Board’s General Segment, established under the JSE’s Market Segmentation framework. Cilo Cybin, the first Cannabis Special Purpose Acquisition Vehicle (SPAC) to list on the AltX Board in June 2024, today transitions to the JSE Main Board where it seeks to pursue additional growth avenues, both organic and through further acquisitions.

 

Published 29 Sep 2025
Posted by NdivhuwoM

Johannesburg, 29 September 2025 – The company has successfully transitioned from AltX to the Main Board General Segment, following the Financial Sector Conduct Authority’s (FSCA) approval of amendments to the Listings Requirements in September 2024 as part of the JSE’s Market Segmentation Project. These amendments introduced two distinct Main Board segments: Prime and General, designed to align regulatory frameworks with issuers’ size and liquidity.

Since the General Segment’s launch last year, over 30 companies have migrated to this segment, reflecting the appeal for companies seeking to benefit from the JSE’s commitment to providing a flexible, supportive regulatory environment that promotes growth by providing more enabling capital raising measures, significant cost savings, efficient and cost effective financial reporting as well as greater flexibility for the boards to manage the business.

“Cilo Cybin's transition from AltX to the Main Board in just over a year highlights the Market Segmentation Project's success in providing a clear path for companies to grow and advance their market position. This framework supports the needs of companies of differing sizes and liquidity levels and enables them to raise capital and undertake corporate actions within an appropriate and relevant regulatory framework while maintaining investor confidence in our market," said Maurice Madiba, Head: Primary Markets at the JSE.

The move to the Main Board provides Cilo Cybin with improved visibility and a broader investor base, ensuring access to greater capital for growth. As part of its classification in the General Segment, the company can now apply an automatic annual rolling general authority to issue shares for cash, representing up to 10% of its issued share capital, without requiring shareholders’ approval. Additionally, it also removes the requirement for fairness opinions for related party transactions/corporate actions, with more emphasis placed on shareholders’ approval, disclosure and the corporate governance processes applied. 

“This is an exciting milestone for Cilo Cybin," said Gabriel Theron, CEO and Founder of Cilo Cybin. "Our journey as a SPAC on the AltX has been critical for us to establish solid foundations in order to make the transition to a Main Board listing. This listing cements our position as a valuable medical cannabis company in South Africa and enhances our ability to attract capital to increase our manufacturing scale and improve our competitiveness as we focus on expanding into new markets. Our growth trajectory and achievements to date positions us to grow our international footprint in the emerging cannabis industry and deliver value to our shareholders." 

Cilo Cybin focuses on identifying viable investments in Biotech, Biohacking and Pharmaceutical businesses in the medical cannabis market.

"It is inspiring to see companies mature on the exchange to a point where they outgrow the AltX’s capabilities and qualify to transition to the on the JSE’s Main Board. The JSE is committed to further creating an enabling environment for listed companies and supporting them in line with their increased size and operations, ensuring they are able to remain competitive in an emerging sector which is poised for growth globally," concludes Madiba. 

ENDS

ABOUT THE JSE

The Johannesburg Stock Exchange (JSE) has a well-established history of operating as a marketplace for trading financial products. It is a pioneering, globally connected exchange group that enables inclusive economic growth through trusted, world-class, socially responsible products, and services for the investor of the future. It offers secure and efficient primary and secondary capital markets across a diverse range of securities, spanning equities, derivatives, and debt markets. It prides itself on being the market of choice for local and international investors looking to gain exposure to leading capital markets on the African continent.

The JSE is currently ranked in the Top 20 largest stock exchanges in the world by market capitalisation, and is the largest stock exchange in Africa, having been in operation for 137 years. As a leading global exchange, the JSE co-creates, unlocks value and makes real connections happen. www.jse.co.za

The JSE takes your privacy seriously in accordance with the POPI Act. We endeavour to only send you relevant information that we think will be of interest to you and the media title you work at. No action is required if you are happy to continue receiving JSE news and information. Should you change your mind at any time in the future, please do let us know. If you do not wish to receive JSE news and information, please respond to this email and we will remove you from future distributions.

JSE general enquiries:

Email:  [email protected] 

Tel: 011 520 7000

JSE media contact: 

Paballo Makhetha

Communication Specialist

Tel: 011 520 7331 

Mobile: 066 261 7405

Email: [email protected]